Molecular Imaging of Gastroenteropancreatic Neuroendocrine Tumors
Somatostatin-receptor scintigraphy has become an obligatory molecular imaging method in the management of patients with neuroendocrine tumors when metastatic disease is suspected. Using positron emission tomography and new somatostatin analogues,…